´╗┐Recognition of mutations in Z disk proteins, such as and in individuals with HCM has further emphasized the part of sarcomere in modulating hypertrophic signalling pathways [48,87]

´╗┐Recognition of mutations in Z disk proteins, such as and in individuals with HCM has further emphasized the part of sarcomere in modulating hypertrophic signalling pathways [48,87]. According to our current understanding, cardiac hypertrophy in HCM is the consequence of activation of various signalling pathways activated from the causal mutations Fluocinonide(Vanos) in sarcomeric proteins (excluding […]